I got into this one at 40c average and done exceptionally well so far. API finally turn the business around and debt well managed. Well done API board. Just not sure if it is best time to sell out. API is running much more efficient. We had challenges from DHL direct (after Pfizer left API), but API managed to continue grow margin and revenue. So well done.
May be Pfizer might craw back to API... LOL
with a bullet, page-31
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
